Verity Presents: 340B Outlook from Capitol Hill and the States

SPONSORED CONTENT

Will you be attending the 340B Winter Coalition Conference in San Diego? Start your week with the latest developments in the 340B program. This year, Verity Solutions will be hosting a panel discussion on Monday morning with some of the most respected long-term

Read More »

RxStrategies’ Launches “340B Insider Podcast” Series

In the episode “340B Insights: The Current State of the 340B Program,” RxStrategies’ Jonathan Ghenn and Rhodie Smith connect with Ted Slafsky, Publisher and CEO of the 340B Report to share information on what’s important to Covered Entities and pharmacy professionals who manage a 340B Program and provide the best care to those they serve.

Read More »

Contract Pharmacies: An Integral 340B Component for 30 Years

SPONSORED CONTENT

This past November, the 340B program celebrated its 30th anniversary—a huge milestone and a reason to rejoice and reflect. We are dismayed, however, that certain drug manufacturers are trying to revise the 340B program’s past and reimagine its future. More than 20 drug manufacturers have unilaterally and unlawfully placed restrictions on contract pharmacy arrangements which have diminished the value

Read More »

What’s the Secret to 340B and Specialty Pharmacy Provider and Patient Engagement?

SPONSORED CONTENT

The rise in digital technologies in the healthcare sector during the COVID-19 pandemic has resulted in some interesting trends in medical communication as we move closer to a post-pandemic world.

During the pandemic, patients became more engaged with medical communication than ever. They went from attending doctor’s visits in-person to making telehealth appointments. In addition, due to forced shutdowns, even the

Read More »

The Potential Domino Effect of Tennessee’s HIV Federal Funding Cuts

Jennifer Lockwood headshot

SPONSORED CONTENT

On January 17th 2023, a letter was sent from the Tennessee Department of Health (DOH) to Tennesseans serving “as notification of changes in the HIV Program.”  The letter informed federal grantees that they will no longer receive CDC funded HIV ‘in-kind support and services’ and will need to find their own

Read More »

In Wake of 340B Contract Pharmacy Restrictions, Biosimilars Deserve Consideration

SPONSORED CONTENT

Recent surveys confirm what those of you reading this know painfully well: Hospital and clinic pharmacies are struggling from the restrictions drug manufacturers are placing on 340B pricing at contract pharmacy sites. As the 340B world awaits another batch of court rulings and hopes for the best, the exclusions are harming patients’ ability

Read More »

Staffing Success for a 340B Pharmacy

Sandie Shafer, Senior Talent Advisor, Pharmacy Operations, Maxor National Pharmacy Services featured image
Sandie Shafer, Senior Talent Advisor, Pharmacy Operations, Maxor National Pharmacy Services

SPONSORED CONTENT

The healthcare industry is grappling with a severe staffing shortage, and pharmacies are no exception. More than three-quarters of community pharmacists are struggling to fill open positions, and nearly 90% say finding pharmacy technicians is their top staffing problem, according to a recent survey by the National Community Pharmacists Association.

As a

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

×

*Sign up for news summaries and alerts from 340B Report

Site Footer